What the The Leukemia & Lymphoma Society TV commercial - Remember This Day is about.
The Leukemia & Lymphoma Society TV Spot, 'Remember This Day' is a heartwarming commercial that aims to raise awareness about blood cancer. The commercial features cancer patients, survivors, and their families expressing their emotions and experiences of dealing with cancer while asking for donations to help fund cancer research and support patients and their families.
The spot opens with a cancer patient sitting in front of the camera, expressing his gratitude to the supporters of The Leukemia & Lymphoma Society for helping him continue his cancer treatment. The camera then pans over to another patient playing with his daughter, talking about how he still wants to be there for her in the future, despite his illness.
Throughout the commercial, the audience is presented with various scenarios of cancer patients and their families, all expressing their hope and gratitude towards The Leukemia & Lymphoma Society for the support they have received. The voices heard are a quiet reminder that cancer does not discriminate and can affect anyone at any time.
The commercial culminates to a call to action, asking the viewer to "Remember This Day" and make a difference by donating to The Leukemia & Lymphoma Society. The overall message of the spot is clear: the fight against cancer is ongoing, but with the help of the society and its supporters, hope and progress towards better treatment and eventual cures can be achieved.
In conclusion, The Leukemia & Lymphoma Society TV Spot, 'Remember This Day' is a powerful reminder of the importance of cancer research and the vital role of support services in the lives of cancer patients and their families.
The Leukemia & Lymphoma Society TV commercial - Remember This Day produced for
The Leukemia & Lymphoma Society
was first shown on television on February 5, 2020.
Frequently Asked Questions about the leukemia & lymphoma society tv spot, 'remember this day'
The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. We are the largest nonprofit funder of blood cancer research, investing more than $1.6 billion in the most pioneering science worldwide since 1949.
In 1949, Rudolph and Antoinette Roesler de Villiers, who lost their teenage son, Robert, to leukemia in 1944, established the first incarnation of what became The Leukemia & Lymphoma Society. The impact was felt right away and the 1950s and 1960s saw some major treatment advances that were revolutionary for the time.
The Leukemia & Lymphoma Society was founded in 1949 by a family for families. We are celebrating 70 years of impact on generations of patients, survivors, families, caregivers, researchers, volunteers, healthcare professionals and supporters who share our relentless drive to find cancer cures.
LLS accepts funding from corporate donors, including pharmaceutical, medical device and insurance industries when it identifies companies that will provide support for LLS programs, research or fundraising/campaign events. LLS applies for industry funding through grant requests to individual companies.
On first usage, always include the ® mark following “Society” (formatted superscript). On second reference you may say “LLS”, never say “the Society.”
Leukemia and lymphoma are easily confused because they're both types of blood cancer. Leukemia usually occurs in bone marrow, while lymphoma originates in the lymphatic system and mainly targets lymph nodes and lymph tissue.
The early history of leukemia reaches back 200 years. In 1811, Peter Cullen defined a case of splenitis acutus with unexplainable milky blood. Alfred Velpeau defined the leukemia associated symptoms, and observed pus in the blood vessels (1825). Alfred Donné detected a maturation arrest of the white blood cells (1844).
John Hughes Bennett (Figure 3), pathologist at the Royal Infirmary Edinburgh, gave leukemia its first published recognition as a clinical entity and as a blood-related disease. He was then often referred to as the person who first discovered leukemia because his description was more complete and scientific in nature.
The early history of leukemia reaches back 200 years. In 1811, Peter Cullen defined a case of splenitis acutus with unexplainable milky blood. Alfred Velpeau defined the leukemia associated symptoms, and observed pus in the blood vessels (1825). Alfred Donné detected a maturation arrest of the white blood cells (1844).
LLS is the largest voluntary cancer research agency specifically focused on finding cures and better treatments for blood cancer patients. With the scope and scale to fund many significant research projects simultaneously, LLS funds hundreds of cancer scientists worldwide.
Leukemia treatments are costly for a number of reasons. Pharmaceutical companies classify chemotherapy and other medications used to treat leukemia as specialty drugs, which aim to treat complex or chronic conditions and are particularly expensive.
To pay tribute or honor the memory of a someone who has touched your life, you can designate your gift as a tribute or a memorial when you make your gift online or by mail or by telephone. We will notify the honoree or the family of your thoughtfulness with a personalized card.
